Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irene Ferrer

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Signal Transduction and Targeted Therapy|November 5, 2025
CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancerMaría Otero-Rosales, Miguel Álvarez-González, Irene Pazos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2026
Combination of Lurbinectedin plus Irinotecan: Preclinical and Early Clinical Results in Relapsed Small Cell Lung Cancer PatientsSantiago Ponce, Miguel Ruiz-Torres, Alejandro Falcón, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without ToxicityMarta Compte, Seandean L Harwood, Ainhoa Erce-Llamazares, et al.
EMBO Molecular Medicine|January 16, 2026
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinumSara Bernardo, Lisa Brunet, Quentin Dominique Thomas, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to DasatinibIrati Garmendia, María J Pajares, Francisco Hermida-Prado, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Nature Medicine|April 12, 2022
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanismCátia Monteiro, Lauritz Miarka, María Perea-García, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Signal Transduction and Targeted Therapy|November 5, 2025
CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancerMaría Otero-Rosales, Miguel Álvarez-González, Irene Pazos, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2026
Combination of Lurbinectedin plus Irinotecan: Preclinical and Early Clinical Results in Relapsed Small Cell Lung Cancer PatientsSantiago Ponce, Miguel Ruiz-Torres, Alejandro Falcón, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2021
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without ToxicityMarta Compte, Seandean L Harwood, Ainhoa Erce-Llamazares, et al.
EMBO Molecular Medicine|January 16, 2026
NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinumSara Bernardo, Lisa Brunet, Quentin Dominique Thomas, et al.
American Journal of Respiratory and Critical Care Medicine|June 6, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to DasatinibIrati Garmendia, María J Pajares, Francisco Hermida-Prado, et al.
Nature Communications|October 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancerIrati Macaya, Marta Roman, Connor Welch, et al.
Nature Medicine|April 12, 2022
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanismCátia Monteiro, Lauritz Miarka, María Perea-García, et al.
Pageof 7